| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.201 | 3.287 | 28.435 | 36.553 |
| Total Income - EUR | - | - | - | - | - | - | 1.201 | 3.287 | 28.437 | 36.559 |
| Total Expenses - EUR | - | - | - | - | - | - | 172 | 1.163 | 11.968 | 19.755 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.029 | 2.125 | 16.468 | 16.804 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 994 | 2.026 | 16.189 | 15.871 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 2 |
Check the financial reports for the company - B&D Willamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 1.201 | 2.137 | 17.656 | 21.113 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 1.201 | 1.647 | 12.829 | 15.581 |
| Cash | - | - | - | - | - | - | 0 | 491 | 4.827 | 5.532 |
| Shareholders Funds | - | - | - | - | - | - | 1.034 | 2.075 | 16.238 | 19.382 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 167 | 62 | 1.418 | 1.731 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - B&D Willamed S.r.l.